Cardamonin targets Bcl-2 family proteins, activating the caspase cascade, inhibiting the nuclear translocation of NF-κB, STAT3 and mTOR, blocks β-catenin signaling, downregulating cell cycle regulatory proteins, and inhibiting oncogenic signaling to induce apoptosis and arrest the cell cycle, thus halting proliferation and metastasis in various cancer cell types (Javaria et al., 2020). The gene discussed is MTOR; the disease is cancer.